Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.12B
Enterprise Value3.42B
P/E Ratio-7.45
PEG Ratio0.15
Price/Sales Ratio1.89
Price/Book Ratio1.38
Enterprise/Revenue2.04
Enterprise/EBITDA-15.71

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.25
Operating Margin-0.14
AD

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.18

Income Statement

Revenue1.85B
Revenue/Share1.99
Gross Profit1.04B
EBITDA-94.07M
Net Income-329.56M
Diluted EPS-0.42

Balance Sheet

Total Cash470.85M
Total Cash/Share0.6
Total Debt667.9M
Total Debt/Equity0.32
Current Ratio1.7
Book Value Per Share2.9

Price History

52-Week Change-16.78
52-Week High5.27
52-Week Low2.85
Moving Average 50 Days3.44
Moving Average 200 Days3.92

Statistics

Average Volume28.97M
Shares Outstanding791.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.03
Last Split Factor2:1
Last Split DateJuly 16, 2015
AD